Vipin Garg, Altimmune CEO, joins ‘Fast Money’ to discuss Altimmune announcing topline results from its obesity drug trial, potential commercial partnership and more.
Trending
- How to invest $50,000 in 2025 for biggest returns with some risk
- AVGO, HMC, GME, KULR and more
- India’s former PM Manmohan Singh dies aged 92
- Those who never doubted Cameron Skattebo share validation: ‘No one understood what we were looking at’
- The worst-performing Dow stocks in 2025: Analysts’ predictions
- Mark Cuban tried to invest in Musical.ly before it became TikTok
- The tennis stories of 2024, from doping bans and Grand Slam titles to a bee invasion
- An options strategy to generate income on this ‘Dog of the S&P 500’
Altimmune CEO on what’s next for its experimental obesity drug
